✍️ Trichometrics Editorial Team·🩺 Reviewed for medical accuracy
For informational purposes only — consult a healthcare provider before starting treatment.
Female Hair Loss Treatment

Spironolactone for Hair Loss: The Women's Anti-Androgen Guide

Spironolactone is one of the most commonly prescribed treatments for female androgenetic alopecia and PCOS-related hair loss. It works by blocking androgens at the follicle, the same hormone pathway that finasteride targets in men, but through a different mechanism.

Medical Disclaimer: Spironolactone is a prescription medication. This is for informational purposes only. Do not take spironolactone without physician supervision. Mandatory contraception is required for women of childbearing potential.
84%

of women in a 2015 study showed improvement or stabilization of hair loss on 40mg/day spironolactone

, Rathnayake & Sinclair, 2015

Off-label

status in most countries for hair loss, but very commonly prescribed by dermatologists experienced in female hair loss

6–18mo

typical timeline to see maximum benefit, consistent with all hormonal hair loss treatments

How Spironolactone Stops Hair Loss

Androgen Receptor Blockade

Spironolactone's primary hair mechanism is competitive antagonism of androgen receptors in hair follicles. By blocking DHT and testosterone from binding to follicle receptors, it prevents the receptor-mediated signaling that causes follicle miniaturization.

5-Alpha Reductase Inhibition

Spironolactone also inhibits 5-alpha reductase, the enzyme that converts testosterone to the more potent DHT. This dual mechanism (receptor block + reduced DHT production) gives it broader anti-androgenic activity than receptor blocking alone.

Adrenal Androgen Reduction

Spironolactone reduces adrenal androgen production (including DHEA-S and androstenedione). This is particularly relevant for women with PCOS or adrenal hyperandrogenism, where elevated adrenal androgens drive hair loss.

Estrogen-Relative Increase

By reducing androgen activity, spironolactone shifts the estrogen-to-androgen ratio in favour of estrogen. Estrogen is protective for hair follicles, this shift helps maintain the anagen (growth) phase.

Who benefits most: Women with elevated androgens (PCOS, elevated DHEA-S or testosterone), women with signs of androgen excess (acne, hirsutism, irregular cycles), and women with female pattern hair loss who have not responded to minoxidil alone.

Dosing Guide

Dosing is individualized by a physician based on androgen levels, blood pressure, and treatment response.

25–50mg/day
Mild cases / starting dose

Starting dose. Lower side effect burden. May be sufficient for mild androgenetic alopecia or as an add-on to minoxidil. Often used in women concerned about blood pressure effects.

100mg/day
Standard dose

The most common therapeutic dose for hair loss. Evidence shows meaningful improvement at this level. Menstrual irregularity more common; often co-prescribed with oral contraceptive to manage.

150–200mg/day
Elevated androgens / resistant cases

Higher doses used in women with significant hyperandrogenism (PCOS, elevated DHEA-S) or inadequate response to 100mg. Requires closer monitoring of potassium and blood pressure.

Contraindications & Safety

Pregnancy

Absolute

Absolute contraindication, spironolactone is a teratogen that causes feminization of male fetuses. Reliable contraception is mandatory for all women of childbearing age taking spironolactone.

Kidney disease / impaired renal function

Absolute

Potassium-sparing effect can cause dangerous hyperkalemia in patients with impaired potassium excretion. Renal function should be assessed before starting.

Elevated baseline potassium (hyperkalemia)

Relative

Spironolactone raises potassium. Women with already-elevated potassium should avoid or use with close monitoring.

ACE inhibitors / ARBs

Caution

Combination with these blood pressure medications significantly increases hyperkalemia risk. Potassium monitoring is mandatory if combination is used.

Track Your Response to Treatment

Spironolactone takes 6–18 months to show maximum benefit, making objective photo tracking essential to confirm it's working before committing long-term. Trichometrics uses AI to analyze your density month by month.

Start Tracking Free

Frequently Asked Questions

How effective is spironolactone for hair loss in women?

Spironolactone is one of the most widely used and effective treatments for female androgenetic alopecia and androgen-driven hair loss. Multiple studies show positive outcomes: a 2015 retrospective study (Rathnayake & Sinclair) found 40mg/day produced improvement in 44% of women and stabilization in 40% , 84% overall benefit. Higher doses (100–200mg/day) show stronger effects in studies with elevated androgens. It is particularly effective in women with PCOS or elevated DHEA-S, where reducing androgen levels addresses the root cause directly.

How long does spironolactone take to work for hair loss?

Spironolactone acts slowly, consistent with all hormonal hair loss treatments. Most women do not see noticeable improvement before 3–6 months of continuous use. The typical protocol involves starting at 50–100mg/day, with assessment at 6 months. Maximum benefit is typically seen at 12–18 months. Like minoxidil, results reverse within months of stopping, spironolactone is ongoing management, not a cure. Combining spironolactone with topical minoxidil is common practice for enhanced benefit.

Can spironolactone cause hair loss initially?

An initial shedding phase in the first 2–8 weeks is possible, as the hormonal shift triggers some follicles to synchronize their cycles. This is transient and does not indicate the treatment is failing. Persistent worsening beyond 3 months on spironolactone warrants reassessment. Rarely, spironolactone itself has been associated with increased body hair (paradoxical hypertrichosis) in a small number of cases, though it more commonly reduces body hair in hyperandrogenic women.

What are the side effects of spironolactone for hair loss?

The most common side effects at hair loss doses (50–200mg/day): menstrual irregularity or spotting (common, often resolves or managed with oral contraceptive combination); breast tenderness or enlargement (20–30%); increased urinary frequency (potassium-sparing diuretic effect); dizziness on standing (orthostatic hypotension, particularly at higher doses); and fatigue. Hyperkalemia (elevated potassium) is a concern at higher doses, particularly in women with kidney disease or those taking ACE inhibitors, potassium levels should be monitored. Spironolactone is absolutely contraindicated in pregnancy, it is a teratogen.